These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34640323)

  • 21. Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction.
    Borrelli C; Gentile F; Sciarrone P; Mirizzi G; Vergaro G; Ghionzoli N; Bramanti F; Iudice G; Passino C; Emdin M; Giannoni A
    Front Cardiovasc Med; 2019; 6():125. PubMed ID: 31555667
    [No Abstract]   [Full Text] [Related]  

  • 22. High-Density Lipoprotein Particle Subfractions in Heart Failure With Preserved or Reduced Ejection Fraction.
    Hunter WG; McGarrah RW; Kelly JP; Khouri MG; Craig DM; Haynes C; Felker GM; Hernandez AF; Velazquez EJ; Kraus WE; Shah SH
    J Am Coll Cardiol; 2019 Jan; 73(2):177-186. PubMed ID: 30654890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of sacubitril/valsartan on cardiac filling pressures in patients with left ventricular systolic dysfunction.
    Khan Z; Gholkar G; Tolia S; Kado H; Zughaib M
    Int J Cardiol; 2018 Nov; 271():169-173. PubMed ID: 30093137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction.
    Olsson KM; Sommer L; Fuge J; Welte T; Hoeper MM
    Respir Res; 2015 Mar; 16(1):34. PubMed ID: 25853979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
    Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
    Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A real-world evaluation of a tertiary care childhood obesity intervention to reduce metabolic risk in a hard-to-reach urban population.
    Bayoumi NS; Helzner E; Afable A; Joseph MA; Dhuper S
    BMC Pediatr; 2019 Oct; 19(1):378. PubMed ID: 31651274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical characteristics of heart failure with recovered ejection fraction].
    Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
    [No Abstract]   [Full Text] [Related]  

  • 28. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial.
    Selvaraj S; Claggett B; Shah SJ; Anand I; Rouleau JL; Desai AS; Lewis EF; Pitt B; Sweitzer NK; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):483-490. PubMed ID: 29148144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction.
    Kresoja KP; Rommel KP; Fengler K; von Roeder M; Besler C; Lücke C; Gutberlet M; Desch S; Thiele H; Böhm M; Lurz P
    Circ Heart Fail; 2021 Mar; 14(3):e007421. PubMed ID: 33706547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Obokata M; Reddy YNV; Pislaru SV; Melenovsky V; Borlaug BA
    Circulation; 2017 Jul; 136(1):6-19. PubMed ID: 28381470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic Significance of Low Systolic Blood Pressure at Discharge in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S; Li X
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):405-412. PubMed ID: 28725953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.
    Bauer A; Khalil M; Lüdemann M; Bauer J; Esmaeili A; De-Rosa R; Voelkel NF; Akintuerk H; Schranz D
    Clin Res Cardiol; 2018 Sep; 107(9):845-857. PubMed ID: 29663123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in clinical biochemical indexes of patients with heart failure with preserved ejection fraction or patients with hypertensive heart disease before and after treadmill exercise.
    Yang X; Xing Y; Li K
    Ann Palliat Med; 2021 Jul; 10(7):7970-7976. PubMed ID: 34353083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
    Ueda T; Kawakami R; Nakada Y; Nakano T; Nakagawa H; Matsui M; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Saito Y
    ESC Heart Fail; 2019 Oct; 6(5):1057-1067. PubMed ID: 31325235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.
    Ahmad AM; Hopkins MT; Weston PJ; Fraser WD; Vora JP
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):431-7. PubMed ID: 11966735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS.
    Visco V; Esposito C; Manzo M; Fiorentino A; Galasso G; Vecchione C; Ciccarelli M
    Front Cardiovasc Med; 2022; 9():874433. PubMed ID: 35445087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of increased pulmonary wedge pressure by an algorithm based on noninvasively measured pulmonary diastolic pressure in cardiac patients independent of left ventricular ejection fraction.
    Barbier P; Cucco C; Guglielmo M; Simioniuc A; Fabiani I; Pugliese NR; Savioli G; Dini FL
    Echocardiography; 2020 Feb; 37(2):215-222. PubMed ID: 32061113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.